DIP Episode 279 - The NBME and Prostaglandins

Source / episode info

• Episode: 279
• Title: Divine Intervention Episode 279 – The NBME and Prostaglandins.
• Published: 2020-12-14
• Source: Episode page

One-liner

This episode provides a comprehensive review of eicosanoid synthesis pathways, detailing how arachidonic acid is converted into prostaglandins and leukotrienes via COX and LOX enzymes, covering clinical applications from antiplatelet therapy (Aspirin) to labor induction and managing congenital heart defects like the Patent Ductus Arteriosus.

High-yield summary

• Arachidonic Acid Source: Membrane phospholipids are cleaved by {PLA}_2 to release Arachidonic Acid ({AA}). This step is inhibited by cortical steroids (e.g., glucocorticoids).
• COX vs LOX Pathways: COX converts AA into prostaglandins and thromboxanes; LOX converts AA into leukotrienes. Both pathways are critical mediators of inflammation, bronchoconstriction, and vascular changes.
• Antiplatelet Mechanism: Aspirin irreversibly inhibits {COX}-1, preventing the synthesis of Thromboxane {A}_2 ({TXA}_2) in platelets, thus exerting its antiplatelet effect.
• Fetal Circulation & PDA: The Patent Ductus Arteriosus (PDA) allows mixing of oxygenated and deoxygenated blood. Neonatal management requires keeping the ductus open; therefore, high levels of supplemental {O}_2 or hyperoxia should be avoided as they cause vasoconstriction and premature closure.
• Prostaglandin Analogs: Synthetic analogs are used clinically: PGE_1 analog (e.g., Prostadil) is first-line for PDA patency; {PGE}_2 analog (e.g., Dinoprostone) can be used for labor induction or cervical ripening.
• Gastroprotection: {NSAI Ds} increase risk of gastric ulcers; prophylactic use of a {PGE}_1 analog like Misoprostol reduces gastric acid secretion and provides mucosoprotection.

Learning objectives

• Describe the biochemical pathways (COX and LOX) responsible for eicosanoid synthesis from arachidonic acid.
• Differentiate the clinical uses of specific prostaglandin analogs (\text{PGE}_1 vs \text{PGE}_2) in obstetrics and neonatology.
• Explain the mechanism by which aspirin exerts its antiplatelet effect via irreversible inhibition of COX-1.
• Identify the risk factors associated with eicosanoid pathway dysregulation, such as Aspirin Exacerbated Respiratory Disease (AERD).
• Understand the physiological basis for PDA patency and the dangers of hyperoxia in neonates.

Board exam buzzwords

Rapid review table

Board-speak -> diagnosis

Differential diagnosis / distinguishing features

PDA Patency Agents

Management pearls

• PDA Management: If a neonate has suspected PDA, administer an \text{PGE}_1 analog (e.g., Iloprost) to maintain ductal flow and prevent premature closure due to hyperoxia or vasoconstrictors.
• NSAID Prophylaxis: For patients requiring chronic NSAI Ds (e.g., for inflammatory joint conditions), prophylactic administration of a \text{PGE}_1 analog like Misoprostol is recommended to reduce gastric acid secretion and protect the mucosa.
• Aspirin Use in Asthma: In patients with asthma, aspirin should be used cautiously or avoided entirely due to the risk of triggering an acute exacerbation via the LOX pathway shunt mechanism (AERD).
• Labor Induction: \text{PGE}_2 analogs (e.g., Dinoprostone) are effective for cervical ripening and stimulating uterine contractions; however, they can also induce fever and pain sensations.

Don't miss

Integration & clinical reasoning

• Inflammation & Vasoconstriction: Many inflammatory mediators (prostaglandins, leukotrienes) are powerful vasoconstrictors. Chronic systemic inflammation can lead to increased Systemic Vascular Resistance (\text{SVR}), contributing to hypertension seen in autoimmune diseases (e.g., scleroderma).
• Pharmacology Synergy: The use of \text{PGE}_1 analogs for PDA patency and Misoprostol for gastroprotection highlights the clinical utility of mimicking natural, protective prostanoid actions when endogenous synthesis is compromised or needs to be maintained.
• Fetal vs Neonatal Physiology: Understanding that fetal circulation relies on temporary shunts (like the PDA) which are sensitive to oxygen tension is crucial for managing neonatal critical care.

Concept connections / cross-references

• For detailed review of inflammatory mediators and their roles in various organs, see [Episode 37] (if available).
• For general pharmacology principles regarding enzyme inhibition, see [Episode 12] (if available).

High-yield association table

Key terms glossary

Study optimization

Question pattern recognition

• AERD Pattern: Asthma exacerbation following \text{NSAID} use -> Suggests a metabolic shunt from \text{COX} -> \text{LOX} pathway, leading to massive leukotriene production and bronchospasm.
• PDA Management Pattern: Neonate with suspected PDA + High \text{O}_2 or vasoconstrictors -> Think of premature closure; administer a \text{PGE}_1 analog (e.g., Iloprost).
• Gastroprotection Pattern: Chronic \text{NSAID} use leading to GI symptoms -> Prophylaxis with Misoprostol (\text{PGE}_1 analog) is preferred over standard PP Is/\text{H}_2 blockers due to its specific mechanism.

Test yourself

Common mistakes to avoid

Common traps

OMM / COMLEX integration

• Reproductive Organ Innervation: Ovaries and testes receive sympathetic innervation from T10–T11 (superior mesenteric/aorticorenal), while the uterus, cervix, prostate, and erectile tissue receive sympathetics from T12–L2 (inferior mesenteric/hypogastric plexus). Parasympathetics arise from pelvic splanchnic nerves (S2–S4).
• Sacral Biomechanics in Pregnancy & Labor: During the first stage of labor, bilateral sacral extension (counternutation) opens the pelvic inlet to accommodate the fetal head. In the second stage, bilateral sacral flexion (nutation) flares the ischial tuberosities to expand the pelvic outlet. Sacral shear or unilateral torsions complicate labor progress and can be relieved with sacral rocking and piriformis counterstrain.
• Chapman Reflex Points: Uterus: Superior pubic ramus. Ovaries/broad ligament: Pubic tubercle to 2 inches lateral, and posterior aspect of the iliotibial band.